Aterian, Inc.(ATER)Earnings, Financials & Key RatiosAterian, Inc. (ATER) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's fundamental viability is challenged by a 99.9% revenue contraction and a critical liquidity position with only $2.3M in cash remaining.
Aterian, Inc. (ATER) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Aterian, Inc. (ATER) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.39vs $0.69+43.5% | $18Mvs $16M+13.8% |
| Q2 2026 | Mar 23, 2026 | $0.50vs $0.58+13.8% | $15Mvs $18M-17.7% |
| Q4 2025 | Nov 13, 2025 | $0.28vs $0.63+55.6% | $19Mvs $18M+3.5% |
| Q3 2025 | Aug 13, 2025 | $0.63vs $0.54-16.7% | $19Mvs $20M-2.1% |
Recent stock market news and headlines for Aterian, Inc. (ATER)
Board-Approved Transactions Expected to Return $0.85–$1.14 Per Share to Stockholders Board-Approved Transactions Expected to Return $0.85–$1.14 Per Share to Stockholders
NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) ("Aterian" or the "Company"), a technology-enabled consumer products company, today reminded its stockholders of the upcoming Special Meeting of Stockholders to be held virtually this week on July 10, 2026 at 10:00 a.
SUMMIT, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced that it has mailed proxy materials previously filed with the U.S. Securities and Exchange Commission (“SEC”) associated with the Special Meeting of Stockholders of the Company (the “Special Meeting”) in connection with the previously announced sale of the Company's marquee brands and an investment of $7.0 million in preferred stock of the Company.
Key metrics vs top competitors for Aterian, Inc. (ATER)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.24 | $13.42M | -0.52 | -30.36% | -27.52% | -83.95% | — | |
| $14.68 | $1.61B | -453.09 | 10.18% | -1.8% | -60.88% | — | |
| $245.98 | $2.65T | 34.31 | 12.38% | 12.22% | 23.34% | — | |
| $28.04 | $3.44B | 2140.46 | 13.04% | 0.15% | 0.37% | — | |
| $74.30 | $1.87B | 22.72 | 2.52% | 3.02% | 9.67% | — | |
| $4.12 | $729.11M | 37.45 | 6.09% | 9.4% | 9.68% | — |
Aterian, Inc. (ATER) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Aterian, Inc. (ATER) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 21, 2026·SEC
Apr 29, 2026·SEC
Mar 23, 2026·SEC
Get notified when ATER posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aterian, Inc. (ATER) stock FAQ — growth, dividends, profitability & financials explained
Aterian, Inc. (ATER) reported $53.6M in revenue for fiscal year 2025. This represents a 47% increase from $36.5M in 2017.
Aterian, Inc. (ATER) saw revenue decline by 30.4% over the past year.
Aterian, Inc. (ATER) reported a net loss of $21.2M for fiscal year 2025.
Aterian, Inc. (ATER) has a return on equity (ROE) of -83.9%. Negative ROE indicates the company is unprofitable.
Aterian, Inc. (ATER) had negative free cash flow of $7.4M in fiscal year 2025, likely due to heavy capital investments.
